Clinical Trial Update: A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor [Phase 1]

View source ↗

Summary

This clinical trial update notes a Phase 1 study of the investigational therapy HDM2005 in patients with relapsed or refractory B-cell lymphoma and advanced sol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Solid Tumor

Drugs mentioned

• HDM2005

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumors, Refractory Lymphoma | Phase 1 | Status: RECRUITING